Cure TV

Bethany Andrews Rhoten, Assistant Professor of Nursing, Vanderbilt University, discusses body images among patients and survivors of head and neck cancer.

Kaunitz says that hot flashes and fatigue are the most commonly experience side effects.

What is bioidentical hormone therapy? Andrew M. Kaunitz answers this important question.

Anees B. Chagpar, director of the Breast Center at Smilow Cancer Hospital at Yale-New Haven, discusses what a patient can expect following a contralateral prophylactic mastectomy.

Anees B. Chagpar, director of the Breast Center at Smilow Cancer Hospital at Yale-New Haven, provides an overview of contralateral prophylactic mastectomy.

Lecia V. Sequist, discusses the adverse event profiles of rociletinib (CO-1686) and osimertinib (AZD9291).

Lecia V. Sequist, associate professor of medicine, Massachusetts General Hospital, provides an overview of T790M, a mutation in the epidermal growth factor receptor (EGFR) gene.

"We can actually improve quality of life," Sharon L. Bober says. "Why wouldn't we want to do that for everyone?"

Sharon L. Bober, director, Sexual Health Program, Dana-Farber Cancer Institute, discusses changes in sexual health as they relate to different treatments for cancer.

Shaji Kumar, professor of medicine, Division of Hematology, Mayo Clinic, discusses common treatment-related adverse events from monoclonal antibodies in patients with multiple myeloma.

Marianne Davies, from Smilow Cancer Hospital, Yale School of Nursing, provides an overview of immunotherapy-related side effects that patient with lung cancer may experience.

There are many clinical trial opportunities, Tolaney says, before surgery.

Finn says it's important for advocacy organizations to attend and socialize at these conferences to explore possible collaborations.

Jacquelyn Powers, genetic counselor, Abramson Cancer Center, University of Pennsylvania, discusses how to empower patients with information regarding genetic testing.

Jacquelyn Powers, genetic counselor, Abramson Cancer Center, University of Pennsylvania, discusses when individuals should consider genetic testing.

Gregory J. Riely, associate attending physician, Memorial Sloan Kettering Cancer Center, discusses identifying and treating patients with MET exon 14 skipping mutations in lung cancer.

Gregory J. Riely, associate attending physician, Memorial Sloan Kettering Cancer Center, provides an overview of MET exon 14 skipping mutations in lung cancer.

Kim Statham Ringen, DVM DACVIM (Oncology), a CURE contributor who is currently surviving stage 4 non-small cell lung cancer, discusses the importance of meeting other cancer survivors.

Kim Statham Ringen, DVM DACVIM (Oncology), a CURE contributor who is currently surviving stage 4 non-small cell lung cancer, discusses the stigma of lung cancer.

Debra Patt from Texas Oncology and The US Oncology Network discusses some challenges patients face when trying to enroll in the Health Insurance Marketplace.

Debra Patt, from Texas Oncology and The US Oncology Network, discusses the impact of health care reform on patients with cancer.

Fred R. Hirsch, from the University of Colorado and IASLC, discusses some of the unique challenges he faced as a patient.

Bonnie J. Addario discusses the background of the "Genomics of Young Lung Cancer" study.

Susan Krigel, from the Midwest Cancer Alliance, discusses the effect of fear of recurrence on a cancer survivor's quality of life.

Susan Krigel, from the Midwest Cancer Alliance, discusses fear of recurrence among cancer survivors.

Michelle Esser, program manager for research and advocacy, Young Survival Coalition, discusses two encouraging studies presented during the 2015 annual meeting of the American Society of Clinical Oncology (ASCO).

Anjee Davis, president, Fight Colorectal Cancer, discusses the future of research in colorectal cancer and the importance of research advocates.

Jill Stopfer, from the University of Pennsylvania, provides an overview of some limitations of multigene panel testing.